+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Region: Trend Forecast and Growth Opportunity

  • ID: 5569593
  • Report
  • March 2022
  • Region: Global
  • 193 Pages
  • GMD Research
Global bioanalytical testing services market will reach $7,902.9 million by 2031, growing by 9.1% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.



Highlighted with 88 tables and 111 figures, this 193-page report “Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Region.

Based on Molecule Type, the global market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Small Molecules
  • Large Molecules
  • LC-MS Studies
  • Immunoassays
  • Other Large Molecule Tests

Based Application, the global market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Bioavailability and Bioequivalence Studies
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Absorption, Distribution, Metabolism, Excretion (ADME)
  • Other Applications

By Test Type, the global market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Cell-based Assays
  • Bacterial Cell-based Assays
  • Viral Cell-based Assays
  • Virology Testing
  • In Vitro Virology Testing
  • In Vivo Virology Testing
  • Species-Specific Viral PCR Assays
  • Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
  • Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
  • Viral Serology, Immunogenicity, and Neutralizing Antibodies
  • Method Development Optimization and Validation (MDOV)
  • Biomarker Testing
  • Pharmacokinetic Testing
  • Other Test Types

By Workflow Process, the global market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Sample Preparation
  • Protein Precipitation
  • Liquid-liquid Extraction (LLE)
  • Sample Analysis
  • Hyphenated Technique
  • Chromatographic Technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance
  • Other Workflow Processes

By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Oncology
  • Neurology
  • Infectious Diseases
  • Gastroenterology
  • Cardiology
  • Other Therapeutic Areas

By End User, the global market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Pharma and Biopharma Companies
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Contract Research Organizations (CROs)

Geographically, the following regions together with the listed national/local markets are fully investigated:

  • North America (U.S., Canada, and Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue ($mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • Charles River Laboratories International Inc.
  • Covance Inc.
  • Eurofins Scientific
  • ICON PLC
  • Intertek Group PLC
  • IQVIA Holdings, Inc.
  • Laboratory Corporation of America Holdings
  • Medpace Holdings, Inc.
  • Pace Analytical Services LLC.
  • Parexel International Corporation
  • PPD Inc.
  • SGS SA
  • Syneos Health, LLC
  • Toxikon Corporation
  • WuXi Apptech Co., Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the Global Bioanalytical Testing Services Market

What is the estimated value of the Global Bioanalytical Testing Services Market?

The Global Bioanalytical Testing Services Market was estimated to be valued at $3314.0 Million in 2021.

What is the growth rate of the Global Bioanalytical Testing Services Market?

The growth rate of the Global Bioanalytical Testing Services Market is 9.1%, with an estimated value of $7903.0 Million by 2031.

What is the forecasted size of the Global Bioanalytical Testing Services Market?

The Global Bioanalytical Testing Services Market is estimated to be worth $7903.0 Million by 2031.

Who are the key companies in the Global Bioanalytical Testing Services Market?

Key companies in the Global Bioanalytical Testing Services Market include Charles River Laboratories International Inc., Covance Inc., Eurofins Scientific, ICON PLC, Intertek Group PLC, IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, Medpace Holdings, Inc. and Parexel International Corporation.

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of Global Market by Molecule Type
3.1 Market Overview by Molecule Type
3.2 Small Molecules
3.3 Large Molecules
3.3.1 LC-MS Studies
3.3.2 Immunoassays
3.3.3 Other Large Molecule Tests
4 Segmentation of Global Market by Application
4.1 Market Overview by Application
4.2 Bioavailability and Bioequivalence Studies
4.3 Pharmacokinetics (PK)
4.4 Pharmacodynamics (PD)
4.5 Absorption, Distribution, Metabolism, Excretion (ADME)
4.6 Other Applications
5 Segmentation of Global Market by Test Type
5.1 Market Overview by Test Type
5.2 Cell-based Assays
5.2.1 Bacterial Cell-based Assays
5.2.2 Viral Cell-based Assays
5.3 Virology Testing
5.3.1 In Vitro Virology Testing
5.3.2 In Vivo Virology Testing
5.3.3 Species-Specific Viral PCR Assays
5.4 Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
5.4.1 Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
5.4.2 Viral Serology, Immunogenicity, and Neutralizing Antibodies
5.5 Method Development Optimization and Validation (MDOV)
5.6 Biomarker Testing
5.7 Pharmacokinetic Testing
5.8 Other Test Types
6 Segmentation of Global Market by Workflow Process
6.1 Market Overview by Workflow Process
6.2 Sample Preparation
6.2.1 Protein Precipitation
6.2.2 Liquid-liquid Extraction (LLE)
6.2.3 Solid Phase Extraction (SPE)
6.3 Sample Analysis
6.3.1 Hyphenated Technique
6.3.2 Chromatographic Technique
6.3.3 Electrophoresis
6.3.4 Ligand Binding Assay
6.3.5 Mass Spectrometry
6.3.6 Nuclear Magnetic Resonance
6.4 Other Workflow Processes
7 Segmentation of Global Market by Therapeutic Area
7.1 Market Overview by Therapeutic Area
7.2 Oncology
7.3 Neurology
7.4 Infectious Diseases
7.5 Gastroenterology
7.6 Cardiology
7.7 Other Therapeutic Areas
8 Segmentation of Global Market by End User
8.1 Market Overview by End User
8.2 Pharma and Biopharma Companies
8.3 Contract Development and Manufacturing Organizations (CDMOs)
8.4 Contract Research Organizations (CROs)
9 Segmentation of Global Market by Region
9.1 Geographic Market Overview 2021-2031
9.2 North America Market 2021-2031 by Country
9.2.1 Overview of North America Market
9.2.2 U.S.
9.2.3 Canada
9.2.4 Mexico
9.3 European Market 2021-2031 by Country
9.3.1 Overview of European Market
9.3.2 Germany
9.3.3 U.K.
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Russia
9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2021-2031 by Country
9.4.1 Overview of Asia-Pacific Market
9.4.2 Japan
9.4.3 China
9.4.4 Australia
9.4.5 India
9.4.6 South Korea
9.4.7 Rest of APAC Region
9.5 South America Market 2021-2031 by Country
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America Market
9.6 MEA Market 2021-2031 by Country
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 Other National Markets
10 Competitive Landscape
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
  • Charles River Laboratories International Inc.
  • Covance Inc.
  • Eurofins Scientific
  • ICON PLC
  • Intertek Group PLC
  • IQVIA Holdings, Inc.
  • Laboratory Corporation of America Holdings
  • Medpace Holdings, Inc.
  • Pace Analytical Services LLC.
  • Parexel International Corporation
  • PPD Inc.
  • SGS SA
  • Syneos Health, LLC
  • Toxikon Corporation
  • WuXi Apptech Co., Ltd.

List of Tables:

Table 1. Snapshot of Global Bioanalytical Testing Services Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Health Spending by Region, $ bn, 2013-2020
Table 4. Main Product Trends and Market Opportunities in Global Bioanalytical Testing Services Market
Table 5. Global Bioanalytical Testing Services Market by Molecule Type, 2021-2031, $ mn
Table 6. Global Bioanalytical Testing Services Market: Large Molecules Testing by Technology, 2021-2031, $ mn
Table 7. Global Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 8. Global Bioanalytical Testing Services Market by Test Type, 2021-2031, $ mn
Table 9. Global Bioanalytical Testing Services Market: Cell-based Assays by Type, 2021-2031, $ mn
Table 10. Global Bioanalytical Testing Services Market: Virology Testing by Type, 2021-2031, $ mn
Table 11. Global Bioanalytical Testing Services Market: Serology, Immunogenicity, and Neutralizing Antibodies (SINA) by Type, 2021-2031, $ mn
Table 12. Global Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 13. Global Bioanalytical Testing Services Market: Sample Preparation by Method, 2021-2031, $ mn
Table 14. Global Bioanalytical Testing Services Market: Sample Analysis by Technology, 2021-2031, $ mn
Table 15. Global Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 16. Global Bioanalytical Testing Services Market by End User, 2021-2031, $ mn
Table 17. Global Bioanalytical Testing Services Market by Region, 2021-2031, $ mn
Table 18. Leading National Bioanalytical Testing Services Market, 2021 and 2031, $ mn
Table 19. North America Bioanalytical Testing Services Market by Country, 2021-2031, $ mn
Table 20. U.S. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 21. U.S. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 22. U.S. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 23. Canada Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 24. Canada Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 25. Canada Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 26. Mexico Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 27. Mexico Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 28. Mexico Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 29. Europe Bioanalytical Testing Services Market by Country, 2021-2031, $ mn
Table 30. Germany Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 31. Germany Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 32. Germany Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 33. U.K. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 34. U.K. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 35. U.K. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 36. France Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 37. France Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 38. France Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 39. Spain Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 40. Spain Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 41. Spain Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 42. Italy Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 43. Italy Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 44. Italy Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 45. Russia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 46. Russia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 47. Russia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 48. Bioanalytical Testing Services Market in Rest of Europe by Country, 2021-2031, $ mn
Table 49. APAC Bioanalytical Testing Services Market by Country, 2021-2031, $ mn
Table 50. Japan Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 51. Japan Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 52. Japan Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 53. China Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 54. China Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 55. China Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 56. Australia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 57. Australia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 58. Australia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 59. India Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 60. India Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 61. India Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 62. South Korea Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 63. South Korea Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 64. South Korea Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 65. Bioanalytical Testing Services Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 66. South America Bioanalytical Testing Services Market by Country, 2021-2031, $ mn
Table 67. Argentina Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 68. Argentina Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 69. Argentina Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 70. Brazil Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 71. Brazil Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 72. Brazil Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 73. Chile Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 74. Chile Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 75. Chile Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 76. MEA Bioanalytical Testing Services Market by Country, 2021-2031, $ mn
Table 77. UAE Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 78. UAE Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 79. UAE Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 80. Saudi Arabia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 81. Saudi Arabia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 82. Saudi Arabia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 83. South Africa Bioanalytical Testing Services Market by Application, 2021-2031, $ mn
Table 84. South Africa Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn
Table 85. South Africa Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn
Table 86. Charles River Laboratories International Inc.: Company Snapshot
Table 87. Charles River Laboratories International Inc.: Business Segmentation
Table 88. Charles River Laboratories International Inc.: Product Portfolio

List of Figures:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global Bioanalytical Testing Services Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Leading Causes of Death in the World, 2019-2020, million
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Drivers and Impact Factors of Global Bioanalytical Testing Services Market
Figure 10. Primary Restraints and Impact Factors of Global Bioanalytical Testing Services Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Five Forces Analysis of Global Bioanalytical Testing Services Market
Figure 13. Breakdown of Global Bioanalytical Testing Services Market by Molecule Type, 2021-2031, % of Revenue
Figure 14. Global Addressable Market Cap in 2022-2031 by Molecule Type, Value ($ mn) and Share (%)
Figure 15. Global Bioanalytical Testing Services Market by Molecule Type: Small Molecules, 2021-2031, $ mn
Figure 16. Global Bioanalytical Testing Services Market by Molecule Type: Large Molecules, 2021-2031, $ mn
Figure 17. Global Bioanalytical Testing Services Market by Large Molecules: LC-MS Studies, 2021-2031, $ mn
Figure 18. Global Bioanalytical Testing Services Market by Large Molecules: Immunoassays, 2021-2031, $ mn
Figure 19. Global Bioanalytical Testing Services Market by Large Molecules: Other Large Molecule Tests, 2021-2031, $ mn
Figure 20. Breakdown of Global Bioanalytical Testing Services Market by Application, 2021-2031, % of Sales Revenue
Figure 21. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 22. Global Bioanalytical Testing Services Market by Application: Bioavailability and Bioequivalence Studies, 2021-2031, $ mn
Figure 23. Global Bioanalytical Testing Services Market by Application: Pharmacokinetics (PK), 2021-2031, $ mn
Figure 24. Global Bioanalytical Testing Services Market by Application: Pharmacodynamics (PD), 2021-2031, $ mn
Figure 25. Global Bioanalytical Testing Services Market by Application: Absorption, Distribution, Metabolism, Excretion (ADME), 2021-2031, $ mn
Figure 26. Global Bioanalytical Testing Services Market by Application: Other Applications, 2021-2031, $ mn
Figure 27. Breakdown of Global Bioanalytical Testing Services Market by Test Type, 2021-2031, % of Sales Revenue
Figure 28. Global Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%)
Figure 29. Global Bioanalytical Testing Services Market by Test Type: Cell-based Assays, 2021-2031, $ mn
Figure 30. Global Bioanalytical Testing Services Market by Cell-based Assays: Bacterial Cell-based Assays, 2021-2031, $ mn
Figure 31. Global Bioanalytical Testing Services Market by Cell-based Assays: Viral Cell-based Assays, 2021-2031, $ mn
Figure 32. Global Bioanalytical Testing Services Market by Test Type: Virology Testing, 2021-2031, $ mn
Figure 33. Global Bioanalytical Testing Services Market by Virology Testing: In Vitro Virology Testing, 2021-2031, $ mn
Figure 34. Global Bioanalytical Testing Services Market by Virology Testing: In Vivo Virology Testing, 2021-2031, $ mn
Figure 35. Global Bioanalytical Testing Services Market by Virology Testing: Species-Specific Viral PCR Assays, 2021-2031, $ mn
Figure 36. Global Bioanalytical Testing Services Market by Test Type: Serology, Immunogenicity, and Neutralizing Antibodies (SINA), 2021-2031, $ mn
Figure 37. Global Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Bacterial Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn
Figure 38. Global Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Viral Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn
Figure 39. Global Bioanalytical Testing Services Market by Test Type: Method Development Optimization and Validation (MDOV), 2021-2031, $ mn
Figure 40. Global Bioanalytical Testing Services Market by Test Type: Biomarker Testing, 2021-2031, $ mn
Figure 41. Global Bioanalytical Testing Services Market by Test Type: Pharmacokinetic Testing, 2021-2031, $ mn
Figure 42. Global Bioanalytical Testing Services Market by Test Type: Other Test Types, 2021-2031, $ mn
Figure 43. Breakdown of Global Bioanalytical Testing Services Market by Workflow Process, 2021-2031, % of Revenue
Figure 44. Global Addressable Market Cap in 2022-2031 by Workflow Process, Value ($ mn) and Share (%)
Figure 45. Global Bioanalytical Testing Services Market by Workflow Process: Sample Preparation, 2021-2031, $ mn
Figure 46. Global Bioanalytical Testing Services Market by Sample Preparation: Protein Precipitation, 2021-2031, $ mn
Figure 47. Global Bioanalytical Testing Services Market by Sample Preparation: Liquid-liquid Extraction (LLE), 2021-2031, $ mn
Figure 48. Global Bioanalytical Testing Services Market by Sample Preparation: Solid Phase Extraction (SPE), 2021-2031, $ mn
Figure 49. Global Bioanalytical Testing Services Market by Workflow Process: Sample Analysis, 2021-2031, $ mn
Figure 50. Global Bioanalytical Testing Services Market by Sample Analysis: Hyphenated Technique, 2021-2031, $ mn
Figure 51. Global Bioanalytical Testing Services Market by Sample Analysis: Chromatographic Technique, 2021-2031, $ mn
Figure 52. Global Bioanalytical Testing Services Market by Sample Analysis: Electrophoresis, 2021-2031, $ mn
Figure 53. Global Bioanalytical Testing Services Market by Sample Analysis: Ligand Binding Assay, 2021-2031, $ mn
Figure 54. Global Bioanalytical Testing Services Market by Sample Analysis: Mass Spectrometry, 2021-2031, $ mn
Figure 55. Global Bioanalytical Testing Services Market by Sample Analysis: Nuclear Magnetic Resonance, 2021-2031, $ mn
Figure 56. Global Bioanalytical Testing Services Market by Workflow Process: Other Workflow Processes, 2021-2031, $ mn
Figure 57. Breakdown of Global Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, % of Revenue
Figure 58. Global Addressable Market Cap in 2022-2031 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 59. Global Bioanalytical Testing Services Market by Therapeutic Area: Oncology, 2021-2031, $ mn
Figure 60. Global Bioanalytical Testing Services Market by Therapeutic Area: Neurology, 2021-2031, $ mn
Figure 61. Global Bioanalytical Testing Services Market by Therapeutic Area: Infectious Diseases, 2021-2031, $ mn
Figure 62. Global Bioanalytical Testing Services Market by Therapeutic Area: Gastroenterology, 2021-2031, $ mn
Figure 63. Global Bioanalytical Testing Services Market by Therapeutic Area: Cardiology, 2021-2031, $ mn
Figure 64. Global Bioanalytical Testing Services Market by Therapeutic Area: Other Therapeutic Areas, 2021-2031, $ mn
Figure 65. Breakdown of Global Bioanalytical Testing Services Market by End User, 2021-2031, % of Revenue
Figure 66. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 67. Global Bioanalytical Testing Services Market by End User: Pharma and Biopharma Companies, 2021-2031, $ mn
Figure 68. Global Bioanalytical Testing Services Market by End User: Contract Development and Manufacturing Organizations (CDMOs), 2021-2031, $ mn
Figure 69. Global Bioanalytical Testing Services Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn
Figure 70. Global Market Snapshot by Region
Figure 71. Geographic Spread of Worldwide Bioanalytical Testing Services Market, 2021-2031, % of Sales Revenue
Figure 72. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 73. North American Bioanalytical Testing Services Market, 2021-2031, $ mn
Figure 74. Breakdown of North America Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue
Figure 75. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 76. U.S. Bioanalytical Testing Services Market, 2021-2031, $ mn
Figure 77. Canada Bioanalytical Testing Services Market, 2021-2031, $ mn
Figure 78. Bioanalytical Testing Services Market in Mexico, 2021-2031, $ mn
Figure 79. European Bioanalytical Testing Services Market, 2021-2031, $ mn
Figure 80. Breakdown of European Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue
Figure 81. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 82. Bioanalytical Testing Services Market in Germany, 2021-2031, $ mn
Figure 83. Bioanalytical Testing Services Market in U.K., 2021-2031, $ mn
Figure 84. Bioanalytical Testing Services Market in France, 2021-2031, $ mn
Figure 85. Bioanalytical Testing Services Market in Spain, 2021-2031, $ mn
Figure 86. Bioanalytical Testing Services Market in Italy, 2021-2031, $ mn
Figure 87. Bioanalytical Testing Services Market in Russia, 2021-2031, $ mn
Figure 88. Bioanalytical Testing Services Market in Rest of Europe, 2021-2031, $ mn
Figure 89. Asia-Pacific Bioanalytical Testing Services Market, 2021-2031, $ mn
Figure 90. Breakdown of APAC Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue
Figure 91. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 92. Bioanalytical Testing Services Market in Japan, 2021-2031, $ mn
Figure 93. Bioanalytical Testing Services Market in China, 2021-2031, $ mn
Figure 94. Bioanalytical Testing Services Market in Australia, 2021-2031, $ mn
Figure 95. Bioanalytical Testing Services Market in India, 2021-2031, $ mn
Figure 96. Bioanalytical Testing Services Market in South Korea, 2021-2031, $ mn
Figure 97. Bioanalytical Testing Services Market in Rest of APAC, 2021-2031, $ mn
Figure 98. South America Bioanalytical Testing Services Market, 2021-2031, $ mn
Figure 99. Breakdown of South America Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue
Figure 100. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 101. Bioanalytical Testing Services Market in Argentina, 2021-2031, $ mn
Figure 102. Bioanalytical Testing Services Market in Brazil, 2021-2031, $ mn
Figure 103. Bioanalytical Testing Services Market in Chile, 2021-2031, $ mn
Figure 104. Bioanalytical Testing Services Market in Rest of South America, 2021-2031, $ mn
Figure 105. Bioanalytical Testing Services Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 106. Breakdown of MEA Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue
Figure 107. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 108. Bioanalytical Testing Services Market in UAE, 2021-2031, $ mn
Figure 109. Bioanalytical Testing Services Market in Saudi Arabia, 2021-2031, $ mn
Figure 110. Bioanalytical Testing Services Market in South Africa, 2021-2031, $ mn
Figure 111. Growth Stage of Global Bioanalytical Testing Services Industry over the Forecast Period

Companies Mentioned

  • Charles River Laboratories International Inc.
  • Covance Inc.
  • Eurofins Scientific
  • ICON PLC
  • Intertek Group PLC
  • IQVIA Holdings, Inc.
  • Laboratory Corporation of America Holdings
  • Medpace Holdings, Inc.
  • Pace Analytical Services LLC.
  • Parexel International Corporation
  • PPD Inc.
  • SGS SA
  • Syneos Health, LLC
  • Toxikon Corporation
  • WuXi Apptech Co., Ltd.

Methodology

Loading
LOADING...